Giorgio Racagni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression.
Journal: International journal of molecular sciences
Published: September 05, 2022
Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile?
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 24, 2021
Therapeutic strategies to fight COVID-19: Which is the status artis?
Journal: British journal of pharmacology
Published: January 15, 2021
Chronic Treatment with a Phytosomal Preparation Containing Centella asiatica L. and Curcuma longa L. Affects Local Protein Synthesis by Modulating the BDNF-mTOR-S6 Pathway.
Journal: Biomedicines
Published: October 20, 2020
Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance.
Journal: Cardiovascular diabetology
Published: August 24, 2020
Chronic Restraint Stress Inhibits the Response to a Second Hit in Adult Male Rats: A Role for BDNF Signaling.
Journal: International journal of molecular sciences
Published: August 03, 2020
The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases.
Journal: Medicinal research reviews
Published: June 05, 2020
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review.
Journal: Frontiers in cardiovascular medicine
Published: May 05, 2020
Current pharmacological treatments for COVID-19: What's next?
Journal: British journal of pharmacology
Published: April 08, 2020
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
Journal: Pharmacological research
Published: March 23, 2020
Last Updated: 09/26/2026